Table 1: Two-by-two table for calculations

Table 2: Quality of evidence of included studies

Table 3: Summary of weighted mean sensitivity, specificity, positive predictive value, and negative predictive value for predicting hibernating myocardium from Schinkel et al.*

Table 4: Summary of changes in heart failure symptoms, exercise capacity, and prognosis

Table 5: Weighted mean sensitivity and specificity results for diagnostic accuracy of detection of viable myocardium from 2005 Beanlands et al. systematic review*

Table 6: Prognosis comparing patients with viable and non-viable myocardium and treatment method

Table 7: Characteristics of included viability diagnostic accuracy studies

Table 8: Summary of the thresholds to define viability and functional improvement by study*

Table 9: Study results for diagnostic accuracy of PET in predicting regional functional recovery after revascularization*

Table 10: Stratification variables for regional functional assessment by study*

Table 11: Pooled estimates of sensitivity and specificity by subgroup

Table 12: Pairwise comparisons of sensitivity and specificity by subgroup

Table 13: Study results for diagnostic accuracy of PET in predicting regional functional recovery after revascularization stratified by hypokinetic and akinetic/dyskinetic segments*

Table 14: Study results for diagnostic accuracy of PET in predicting global LV functional recovery after revascularization

Table 15: GRADE quality of evidence for the diagnostic accuracy of PET for the detection of viable myocardium based on regional functional recovery in patients with known CAD

Table 16: GRADE quality of evidence for the diagnostic accuracy of PET for the detection of myocardial viability based on global functional recovery in patients with known CAD

Table 17: Study characteristics of prognostic studies

Table 18: Patient characteristics in prognosis studies

Table 19: Mortality rate by viability status and treatment

Table 20: Study characteristics of prognostic studies

Table 21: Impact of revascularization on exercise capacity

Table 22: GRADE quality of evidence for prognosis studies

Table 23: Study characteristics for contribution of PET viability imaging to treatment decision making

Table 24: Cardiac events stratified by study group

Table 25: GRADE quality of evidence for prognosis studies

Table 26: Summary of radiation exposure dosages associated with PET viability imaging

Table A1: Quality assessment of included systematic reviews with AMSTAR Checklist

Table A2: Quality of studies investigating the accuracy of PET for the detection of regional functional recovery (Part I)

Table A3: Quality of studies investigating the accuracy of PET for the detection of regional functional recovery (Part II)

Table A4: Quality of studies investigating the accuracy of PET for the detection of global functional recovery